Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2017, Article ID 4984951, 6 pages
https://doi.org/10.1155/2017/4984951
Case Report

A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm Extensively Studied by Flow Cytometry and Immunohistochemistry

1Division of Hematology, Niguarda Ca’ Granda Hospital, Milan, Italy
2Department of Laboratory Medicine, Niguarda Ca’ Granda Hospital, Milan, Italy

Correspondence should be addressed to Martina Pennisi; moc.liamg@itram.isinnep

Received 7 November 2016; Revised 6 February 2017; Accepted 20 February 2017; Published 20 March 2017

Academic Editor: Yusuke Shiozawa

Copyright © 2017 Martina Pennisi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Facchetti, D. Jones, and T. Petrella, “Blastic plasmacytoid dendritic cell neoplasm,” in WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues, S. H. Swerdlow, E. Campo, N. L. Hazzis et al., Eds., pp. 145–147, IARC press, Lyon, France, 2008. View at Google Scholar
  2. D. A. Arber, A. Orazi, R. Hasserjian et al., “The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia,” Blood, vol. 127, no. 20, pp. 2391–2405, 2016. View at Google Scholar
  3. F. Facchetti, M. Cigognetti, S. Fisogni, G. Rossi, S. Lonardi, and W. Vermi, “Neoplasms derived from plasmacytoid dendritic cells,” Modern Pathology, vol. 29, no. 2, pp. 98–111, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. A. G. Jegalian, F. Facchetti, and E. S. Jaffe, “Plasmacytoid dendritic cells physiologic roles and pathologic states,” Advances in Anatomic Pathology, vol. 16, no. 6, pp. 392–404, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Swiecki and M. Colonna, “The multifaceted biology of plasmacytoid dendritic cells,” Nature Reviews Immunology, vol. 15, no. 8, pp. 471–485, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Breton, J. Lee, K. Liu, and M. C. Nussenzweig, “Defining human dendritic cell progenitors by multiparametric flow cytometry,” Nature Protocols, vol. 10, no. 9, pp. 1407–1422, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Onai, K. Kurabayashi, M. Hosoi-Amaike et al., “A clonogenic progenitor with prominent plasmacytoid dendritic cell developmental potential,” Immunity, vol. 38, no. 5, pp. 943–957, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. M. R. Sapienza, F. Fuligni, C. Agostinelli et al., “Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-κB pathway inhibition,” Leukemia, vol. 28, no. 8, pp. 1606–1616, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Dijkman, R. Van Doorn, K. Szuhai, R. Willemze, M. H. Vermeer, and C. P. Tensen, “Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities,” Blood, vol. 109, no. 4, pp. 1720–1727, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Lucioni, F. Novara, G. Fiandrino et al., “Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion,” Blood, vol. 118, no. 17, pp. 4591–4594, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Jardin, M. Callanan, D. Penther et al., “Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease,” Leukemia, vol. 23, no. 4, pp. 698–707, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. O. Abdel-Wahab and R. L. Levine, “Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia,” Blood, vol. 121, no. 18, pp. 3563–3572, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Alayed, K. P. Patel, S. Konoplev et al., “TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow,” American Journal of Hematology, vol. 88, no. 12, pp. 1055–1061, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Menezes, F. Acquadro, M. Wiseman et al., “Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm,” Leukemia, vol. 28, no. 4, pp. 823–829, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Stenzinger, V. Endris, N. Pfarr et al., “Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm,” Oncotarget, vol. 5, no. 15, pp. 6404–6413, 2014. View at Google Scholar
  16. C. Cota, E. Vale, I. Viana et al., “Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients,” The American Journal of Surgical Pathology, vol. 34, no. 1, pp. 75–87, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Pagano, C. G. Valentini, A. Pulsoni et al., “Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an italian multicenter study,” Haematologica, vol. 98, no. 2, pp. 239–246, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Laribi, N. Denizon, H. Ghnaya et al., “Blastic plasmacytoid dendritic cell neoplasm: the first report of two cases treated by 5-Azacytidine,” European Journal of Haematology, vol. 93, no. 1, pp. 81–85, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Ferreira, M. G. Gasparinho, and R. Fonseca, “Cytomorphological features of blastic plasmacytoid dendritic cell neoplasm on FNA and cerebrospinal fluid cytology: a review of 6 cases,” Cancer Cytopathology, vol. 124, no. 3, pp. 196–202, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. J.-H. Kim, H.-Y. Park, J.-H. Lee, D.-Y. Lee, J.-H. Lee, and J.-M. Yang, “Blastic plasmacytoid dendritic cell neoplasm: analysis of clinicopathological feature and treatment outcome of seven cases,” Annals of Dermatology, vol. 27, no. 6, pp. 727–737, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. U. Deotare, K. W. L. Yee, L. W. Le et al., “Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: 10-Color flow cytometry diagnosis and HyperCVAD therapy,” American Journal of Hematology, vol. 91, no. 3, pp. 283–286, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Martín-Martín, A. López, B. Vidriales et al., “Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile,” Oncotarget, vol. 6, no. 22, pp. 19204–19216, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. D. L. Jaye, C. M. Geigerman, M. Herling, K. Eastburn, E. K. Waller, and D. Jones, “Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms,” Modern Pathology, vol. 19, no. 12, pp. 1555–1562, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Assaf, S. Gellrich, S. Whittaker et al., “CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer,” Journal of Clinical Pathology, vol. 60, no. 9, pp. 981–989, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Galy, M. Travis, D. Cen, and B. Chen, “Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset,” Immunity, vol. 3, no. 4, pp. 459–473, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. N. R. Bavikatty, C. W. Ross, W. G. Finn, B. Schnitzer, and T. P. Singleton, “Anti-CD10 immunoperoxidase staining of paraffin-embedded acute leukemias: comparison with flow cytometric immunophenotyping,” Human Pathology, vol. 31, no. 9, pp. 1051–1054, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Garnache-Ottou, J. Feuillard, C. Ferrand et al., “Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia,” British Journal of Haematology, vol. 145, no. 5, pp. 624–636, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Pemmaraju, D. A. Thomas, H. Kantarjian et al., “Analysis of outcomes of patients (pts) with blastic plasmacytoid dendritic cell neoplasm (BPDCN),” Journal of Clinical Oncology, vol. 30, supplement, abstract 6578, 2012, Proceedings of the 2012 ASCO Annual Meeting. View at Google Scholar
  29. D. Roos-Weil, S. Dietrich, A. Boumendil et al., “Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: A Retrospective Study from The European Group for Blood and Marrow Transplantation,” Blood, vol. 121, no. 3, pp. 440–446, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Leclerc, R. Peffault de Latour, M. Michallet et al., “Can reduced intensity conditioning regimen cure blastic plasmacytoid dendritic cell neoplasm?” Blood, vol. 129, pp. 1227–1230, 2017. View at Publisher · View at Google Scholar
  31. T. Aoki, R. Suzuki, Y. Kuwatsuka et al., “Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm,” Blood, vol. 125, no. 23, pp. 3559–3562, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Ceribelli, Z. E. Hou, P. N. Kelly et al., “A druggable TCF4- and BRD4-dependent transcriptional network sustains malignancy in blastic plasmacytoid dendritic cell neoplasm,” Cancer Cell, vol. 30, no. 5, pp. 764–778, 2016. View at Publisher · View at Google Scholar
  33. E. M. Carrington, J.-G. Zhang, R. M. Sutherland et al., “Prosurvival Bcl-2 family members reveal a distinct apoptotic identity between conventional and plasmacytoid dendritic cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 13, pp. 4044–4049, 2015. View at Publisher · View at Google Scholar